These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 33717144)

  • 41. Hyper IgE syndromes: clinical and molecular characteristics.
    Al-Shaikhly T; Ochs HD
    Immunol Cell Biol; 2019 Apr; 97(4):368-379. PubMed ID: 30264496
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A deep intronic splice mutation of
    Khourieh J; Rao G; Habib T; Avery DT; Lefèvre-Utile A; Chandesris MO; Belkadi A; Chrabieh M; Alwaseem H; Grandin V; Sarrot-Reynauld F; Sénéchal A; Lortholary O; Kong XF; Boisson-Dupuis S; Picard C; Puel A; Béziat V; Zhang Q; Abel L; Molina H; Marr N; Tangye SG; Casanova JL; Boisson B
    Proc Natl Acad Sci U S A; 2019 Aug; 116(33):16463-16472. PubMed ID: 31346092
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular Assessment of Staphylococcus Aureus Strains in STAT3 Hyper-IgE Syndrome Patients.
    Schwierzeck V; Effner R; Abel F; Reiger M; Notheis G; Held J; Simon V; Dintner S; Hoffmann R; Hagl B; Huebner J; Mellmann A; Renner ED
    J Clin Immunol; 2022 Aug; 42(6):1301-1309. PubMed ID: 35655107
    [TBL] [Abstract][Full Text] [Related]  

  • 44. An Unexpected Infection in Loss-of-Function Mutations in STAT3: Malignant Alveolar Echinococcosis in Liver.
    Haskologlu S; Dogu F; Gollu Bahadır G; Akyuzluer S; Ciftci E; Altun D; Keles S; Kologlu M; Ikinciogullari A
    Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):667-675. PubMed ID: 33463136
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The hyper-IgE syndromes.
    Freeman AF; Holland SM
    Immunol Allergy Clin North Am; 2008 May; 28(2):277-91, viii. PubMed ID: 18424333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. STAT3 Hyper-IgE Syndrome-an Update and Unanswered Questions.
    Tsilifis C; Freeman AF; Gennery AR
    J Clin Immunol; 2021 Jul; 41(5):864-880. PubMed ID: 33932191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyper IgE syndromes: A clinical approach.
    Gharehzadehshirazi A; Amini A; Rezaei N
    Clin Immunol; 2022 Apr; 237():108988. PubMed ID: 35351598
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyper IgE syndrome: an update on clinical aspects and the role of signal transducer and activator of transcription 3.
    Paulson ML; Freeman AF; Holland SM
    Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):527-33. PubMed ID: 18978467
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hyper IgE syndrome associated with novel and recurrent STAT3 mutations: Two case reports.
    Deng Y; Li T; Xie X; Xia D; Ding L; Xiang H; Ma JJ; Li W
    Medicine (Baltimore); 2019 Feb; 98(6):e14003. PubMed ID: 30732127
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Successful haploidentical donor hematopoietic stem cell transplant and restoration of STAT3 function in an adolescent with autosomal dominant hyper-IgE syndrome.
    Patel NC; Gallagher JL; Torgerson TR; Gilman AL
    J Clin Immunol; 2015 Jul; 35(5):479-85. PubMed ID: 25962528
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels.
    Sassi A; Lazaroski S; Wu G; Haslam SM; Fliegauf M; Mellouli F; Patiroglu T; Unal E; Ozdemir MA; Jouhadi Z; Khadir K; Ben-Khemis L; Ben-Ali M; Ben-Mustapha I; Borchani L; Pfeifer D; Jakob T; Khemiri M; Asplund AC; Gustafsson MO; Lundin KE; Falk-Sörqvist E; Moens LN; Gungor HE; Engelhardt KR; Dziadzio M; Stauss H; Fleckenstein B; Meier R; Prayitno K; Maul-Pavicic A; Schaffer S; Rakhmanov M; Henneke P; Kraus H; Eibel H; Kölsch U; Nadifi S; Nilsson M; Bejaoui M; Schäffer AA; Smith CI; Dell A; Barbouche MR; Grimbacher B
    J Allergy Clin Immunol; 2014 May; 133(5):1410-9, 1419.e1-13. PubMed ID: 24698316
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Severe eczema and Hyper-IgE in Loeys-Dietz-syndrome - contribution to new findings of immune dysregulation in connective tissue disorders.
    Felgentreff K; Siepe M; Kotthoff S; von Kodolitsch Y; Schachtrup K; Notarangelo LD; Walter JE; Ehl S
    Clin Immunol; 2014 Jan; 150(1):43-50. PubMed ID: 24333532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bone density and fractures in autosomal dominant hyper IgE syndrome.
    Sowerwine KJ; Shaw PA; Gu W; Ling JC; Collins MT; Darnell DN; Anderson VL; Davis J; Hsu A; Welch P; Puck JM; Holland SM; Freeman AF
    J Clin Immunol; 2014 Feb; 34(2):260-4. PubMed ID: 24402620
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [STAT3 mutation in a child with hyper-IgE syndrome and incomplete clinical features].
    Szaflarska A; Rutkowska-Zapała M; Pituch-Noworolska A; Siedlar M
    Przegl Lek; 2015; 72(12):787-90. PubMed ID: 27024962
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retained primary teeth in STAT3 hyper-IgE syndrome: early intervention in childhood is essential.
    Meixner I; Hagl B; Kröner CI; Spielberger BD; Paschos E; Dückers G; Niehues T; Hesse R; Renner ED
    Orphanet J Rare Dis; 2020 Sep; 15(1):244. PubMed ID: 32912316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Hyper-IgE syndrome in adulthood: a case report and literature review].
    Jin JM; Sun YC; Liu Y; Liu XF; Liu GJ; Han JY; Zeng H
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Jan; 40(1):52-57. PubMed ID: 28100363
    [No Abstract]   [Full Text] [Related]  

  • 57. Genetic origins of hyper-IgE syndrome.
    Minegishi Y; Karasuyama H
    Curr Allergy Asthma Rep; 2008 Sep; 8(5):386-91. PubMed ID: 18682102
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Novel mutation in DOCK8-HIES with severe phenotype and successful transplantation.
    Al Shekaili L; Sheikh F; Al Gazlan S; Al Dhekri H; Al Mousa H; Al Ghonaium A; Al Saud B; Al Mohsen S; Rehan Khaliq AM; Al Sumayli S; Al Zahrani M; Dababo A; AlKawi A; Hawwari A; Arnaout R
    Clin Immunol; 2017 May; 178():39-44. PubMed ID: 27890707
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Human STAT3 variants underlie autosomal dominant hyper-IgE syndrome by negative dominance.
    Asano T; Khourieh J; Zhang P; Rapaport F; Spaan AN; Li J; Lei WT; Pelham SJ; Hum D; Chrabieh M; Han JE; Guérin A; Mackie J; Gupta S; Saikia B; Baghdadi JEI; Fadil I; Bousfiha A; Habib T; Marr N; Ganeshanandan L; Peake J; Droney L; Williams A; Celmeli F; Hatipoglu N; Ozcelik T; Picard C; Abel L; Tangye SG; Boisson-Dupuis S; Zhang Q; Puel A; Béziat V; Casanova JL; Boisson B
    J Exp Med; 2021 Aug; 218(8):. PubMed ID: 34137790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An update on the hyper-IgE syndromes.
    Yong PF; Freeman AF; Engelhardt KR; Holland S; Puck JM; Grimbacher B
    Arthritis Res Ther; 2012 Nov; 14(6):228. PubMed ID: 23210525
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.